Milestone Scientific

Milestone Scientific, Inc. is a biomedical technology research and development company, which patents, designs, and develops diagnostic and therapeutic injection technologies and instruments. It operates through the following segments: Dental, Medical, and Corporate. The Corporate segment refers to executive management, investor relations, patents, trademarks, licensing agreements, new instruments developments, financing activities, and public company compliance costs. Its solutions include CompuFlo Epidural, CathCheck Verification System, and Single Tooth Anesthesia System. The company was founded on August 17, 1989 and is headquartered in Roseland, NJ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Milestone Scientific reports Q1 revenue, eyes international expansion opportunities

Milestone Scientific's Q1 2024 performance showed revenue over $2.2 million with improved gross margins.
The company's focus on customer relationships and reimbursement strategies is a key strength.
Challenges include revenue decrease and the need for endorsements in the medical space.
Opportunities lie in international expansion, market penetration goals, and increased marketing efforts.

Milestone Scientific reports improved Q2 performance amidst revenue challenges

Milestone Scientific showcased financial improvements in Q2 2024 despite a revenue decrease, with a focus on enhancing operational efficiency and achieving positive cash flow.
The company's strategic partnerships, international expansion plans, and commitment to innovation through intellectual property enhancements signal a path for future growth and market competitiveness.
While facing challenges in revenue generation and operational clarity, Milestone Scientific's strong balance sheet and market positioning offer opportunities for sustained growth and profitability.

Milestone Scientific reports revenue growth and strategic partnerships in Q3

Milestone Scientific shows promising revenue growth and operational improvements in Q3 2024, driven by strong Dental division performance and international sales.
Strategic partnerships and a solid financial position enhance market reach and provide a foundation for future growth.
Challenges include reducing net losses, driving market adoption of CompuFlo, and navigating Medicare coverage expansion, while opportunities exist in reimbursement initiatives and market expansion post-approvals.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Milestone Scientific Inc. (NYSE:MLSS ) Q1 2022 Earnings Conference Call May 17, 2022 8:30 AM ET Company Participants Arjan Haverhals - CEO Keisha Harcum - Controller David Waldman - Crescendo Communications, IR Conference Call Participants Anthony Vendetti - Maxim Group Operator Good morning, ladies and gentlemen, and welcome to the Milestone Scientific First Quarter 2022 Business Update Call. At this time, all participants have been placed on a listen-only mode, and the floor will be opened for questions and comments after the presentation.

Milestone Scientific Inc. (MLSS) CEO Arjan Haverhals on Q1 2022 Results - Earnings Call Transcript

ROSELAND, N.J., May 17, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the first quarter ended March 31, 2022.

Milestone Scientific Achieves Revenue of $2.7 Million and Provides Business Update for the First Quarter of 2022

ROSELAND, N.J., May 13, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Tuesday, May 17, 2022, to discuss the company's financial results for the first quarter ended March 31, 2022, as well as the company's corporate progress and other developments.

Milestone Scientific Schedules First Quarter 2022 Financial Results and Business Update Conference Call

Roseland, New Jersey--(Newsfile Corp. - April 29, 2022) - Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that Arjan Haverhals, President and CEO of Milestone Scientific, will present at The Q2 Investor Summit, hosted by the Investor Summit Group, being held on May 3-4, 2022 at The Westin New York Grand Central.Event: The Q2 Investor Summit GroupDate: ...

Milestone Scientific to Present at Investor Summit Group's Q2 In-Person Conference on May 3rd in NYC

A new focus on their Dental business and the easing of the pandemic produced a strong recovery which has legs. The growth of the installed base of devices produces a large tail of high-margin consumables in Dental, but this will ensue with the CompuFlow as well when the base grows.

Milestone Scientific Is Attractive Here

ROSELAND, N.J., April 14, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that Arjan Haverhals, President and CEO of Milestone Scientific, will present at the Noble Capital Markets Eighteenth Annual Investor Conference being held on April 20-21, 2022 at the Hard Rock Hotel & Casino in Hollywood, Florida.

Milestone Scientific to Present at The Noble Capital Markets Eighteenth Annual Investor Conference on April 21st

Milestone and Keystone Dental Group Form Strategic Channel Partnership to Expand the STA Single Tooth Anesthesia ® System within Implant Dentistry

Milestone Scientific Enacts Strategy to Diversify Channel Partnerships and Announces Initiatives to Expand Dental Sales

Milestone Scientific Inc (NYSE:MLSS), the medtech group, revealed that it has begun selling its CompuFlo Epidural and CathCheck Verification System disposables to a leading northeast medical center following a successful trial by the latter. "We are honored to announce adoption of our CompuFlo Epidural and CathCheck Verification System by another leading medical center," said Arjan Haverhals, the CEO of Milestone Scientific.

Milestone Scientific begins sales of its CompuFlo Epidural and CathCheck Verification System disposables to premier US hospital

ROSELAND, N.J., April 11, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today reported that, following a successful trial and evaluation, it has commenced sales of its CompuFlo ® Epidural and CathCheck ™ Verification System disposables to a leading northeast medical center. The hospital has been designated as one of the World's Best Hospitals-USA by Newsweek for the fourth consecutive year.

Milestone Scientific Commences Sales of CompuFlo® Epidural / CathCheck™ Verification System Disposables to a Premier Northeast Hospital

Maxim has lowered the price target on Milestone Scientific Inc (NYSE: MLSS) to $4 from $6 but maintained a Buy rating on the shares.  Analyst Anthony Vendetti reduced the price target due to a higher risk premium on micro-cap stocks.

Here's Why Maxim Reduced Price Target On Milestone Scientific

Milestone Scientific Inc. (MLSS) CEO Arjan Haverhals on Q4 2021 Results - Earnings Call Transcript

Milestone Scientific Inc (NYSE:MLSS) has announced that its fiscal 2021 revenue climbed by 90% year over year to $10.3 million, boosted by a $4.7 million increase in its dental revenue due to the re-opening of dental offices throughout the country and the rest of the world, including China. The company said the results have surpassed its previous revenue guidance and have exceeded pre-pandemic levels.

Milestone Scientific sees its FY2021 revenue surge 90% to $10.3M as dental sales boost results

ROSELAND, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the full year ending December 31, 2021.

Milestone Scientific Reports 90% Year-Over-Year Revenue Growth and Provides 2021 Year-End Business Update

ROSELAND, N.J., March 29, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, April 1, 2022 to discuss the company's financial results for the 2021 fiscal year ended December 31, 2021, as well as the company's corporate progress and other developments.

Milestone Scientific Schedules 2021 Fiscal Year Financial Results and Business Update Conference Call

Milestone Scientific Inc (NYSE:MLSS) said that it has commenced sales of the CompuFlo Epidural disposables at the Cypress Surgery Center in Santa Maria, California and the Galileo Surgery Center in San Luis Obispo.  Both of these prominent pain management practices are located in California and owned by Pain Management Specialists (PMS), a group of specially trained physicians, dedicated to the evaluation and treatment of acute and chronic pain.

Milestone Scientific Inc commences sales of CompuFlo Epidural disposables at two surgery centers in California

ROSELAND, N.J., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that the Company has been invited to present at The MicroCap Rodeo's 2nd Annual Winter Wonderland Best Ideas Conference, which is being held virtually on February 8 - 11, 2022.

Milestone Scientific to Present at MicroCap Rodeo's Winter Wonderland Best Ideas Conference on Wednesday, February 9

ROSELAND, N.J., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide virtually painless and precise injections, today announced that Arjan Haverhals, CEO and president of Milestone Scientific, will participate in a virtual fireside chat hosted by Anthony Vendetti, executive managing director of research at Maxim Group LLC.

Milestone Scientific CEO to Participate in Fireside Chat Hosted by Maxim Group and M-Vest on January 20th

Milestone Scientific Inc (NYSE:MLSS). has prepared investors for an 85% increase in revenue for its 2021 financial year as its dental and medical divisions continue to gain traction.

Milestone Scientific projects 85% rise in 2021 revenue to more than $10M as divisions gain traction

ROSELAND, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide virtually painless and precise injections, today provided revenue guidance for the fourth quarter and year ended December 31, 2021. The Company anticipates revenue of over $2.6 million for the fourth quarter of 2021 compared to $2.2 million for the fourth quarter of 2020 and revenue in excess of $10 million for the fiscal year 2021 compared to revenue of $5.4 million for fiscal 2020.

Milestone Scientific Projects Revenue to Increase Over 85% to More than $10 Million for 2021

ROSELAND, N.J., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Arjan Haverhals, Chief Executive Officer of Milestone Scientific, will be presenting at the H.C. Wainwright BioConnect 2022 Conference being held virtually January 10-13, 2022.

Milestone Scientific to Present at the H.C. Wainwright BioConnect 2022 Conference

Milestone Scientific Inc. announced that it has commenced sales of its CompuFlo Epidural disposables with a prominent pain clinic in North Carolina.   In a statement, the company said leading physician Dr. Harsh Govil, whose practice is based in Statesville, has begun incorporating the CompuFlo Epidural instrument into his practice for pain management following a successful evaluation.

Milestone Scientific commences sales of its CompuFlo Epidural disposables with prominent pain clinic in North Carolina

Reports continued expansion into pain management market following successful evaluation by Dr. Harsh Govil, MD, MPH Reports continued expansion into pain management market following successful evaluation by Dr. Harsh Govil, MD, MPH

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Prominent Pain Clinic with Leading Physician

Milestone Scientific Inc. (NYSE:MLSS) announced the purchase of its CompuFlo Epidural and CathCheck Verification System disposables from two additional leading hospitals. The company added that the new orders will help expand its geographic footprint.

Milestone Scientific announces purchase of its CompuFlo Epidural and CathCheck Verification System disposables at two leading hospitals

Both hospitals belong to large hospital systems representing future growth opportunities Both hospitals belong to large hospital systems representing future growth opportunities

Milestone Scientific Announces Purchase of CompuFlo / CathCheck™ Verification System Disposables at Two Additional Premier Hospitals

Milestone Scientific Inc (NYSE:MLSS) has announced an agreement with medical and dental device company Andau Medical to distribute Milestone's STA Single Tooth Anesthesia System in the US and Canada. “We initially began our collaboration with Andau around our CompuFlo Epidural Instrument in Canada,” Milestone Scientific CEO Arjan Haverhals said in a statement.

News for Milestone Scientific Stock (MLSS)